<DOC>
	<DOCNO>NCT02242396</DOCNO>
	<brief_summary>The primary objective evaluate , use Home blood pressure monitoring ( HBPM ) , degree BP control early morning hour 8 week treatment patient essential hypertension treatment Micardis® , Telmisartan Micardis Plus® , Telmisartan hydrochlorothiazide . The co-primary endpoint degree BP control , change baseline study end mean systolic blood pressure ( mSBP ) mean diastolic blood pressure ( mDBP ) HBPM early morning hour 8 week treatment Micardis® , Telmisartan Micardis Plus® , Telmisartan hydrochlorothiazide . Secondary endpoint office BP control rate , office BP response rate , reduction mSBP mDBP Office blood pressure measurement ( OBPM ) baseline final visit , discontinuation tolerability</brief_summary>
	<brief_title>A Study Hypertensive Population Under Treatment With Micardis® Micardis Plus® Control Early Morning BP Rise ( SURGE II )</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Telmisartan , hydrochlorothiazide drug combination</mesh_term>
	<criteria>Patients male female 18 80 year age Patients mild moderate essential hypertension Patients diagnose hypertension currently take antihypertensive medication previously diagnose hypertensive patient uncontrolled current treatment Premenopausal woman birth control , pregnant nursing Patients advance hepatic impairment advance renal impairment Patients New York Heart Association ( NYHA ) functional class III IV congestive heart failure ( CHF ) , unstable angina , acute myocardial infarction , heart surgery stroke within previous six month Patients type relevant arrhythmia accord assessment investigator Patients valvular disease hemodynamic repercussion Patients receive chronic administration oral anticoagulant digoxin Patients know hypersensitivity component formulation Micardis® , Telmisartan Micardis Plus® , Telmisartan hydrochlorothiazide Patients previous history angioedema associate angiotensin convert enzyme ( ACE ) inhibitor Patients severe , uncontrolled hypertension form secondary hypertension Patients clinical condition , opinion investigator , would allow safe completion protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>